A Look At Sabra Health Care REIT (SBRA) Valuation After Its Recent Share Price Momentum

Simply Wall St.05-04

AdvertisementPerformance snapshot and why Sabra might be on your radar Sabra Health Care REIT (SBRA) has quietly put together a solid run, with the stock up about 2.5% over the past month and roughly ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2632795974?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842","is_english":true,"pubTime":"2026-05-04 22:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2632795974","market":"sg","top_or_hot":-1,"title":"A Look At Sabra Health Care REIT (SBRA) Valuation After Its Recent Share Price Momentum","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementPerformance snapshot and why Sabra might be on your radar Sabra Health Care REIT (SBRA) has quietly put together a solid run, with the stock up about 2.5% over the past month and roughly ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/real-estate/nasdaq-sbra/sabra-health-care-reit/news/a-look-at-sabra-health-care-reit-sbra-valuation-after-its-re\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Sabra Health Care REIT (SBRA) Valuation After Its Recent Share Price Momentum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Sabra Health Care REIT (SBRA) Valuation After Its Recent Share Price Momentum\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-04 22:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/real-estate/nasdaq-sbra/sabra-health-care-reit/news/a-look-at-sabra-health-care-reit-sbra-valuation-after-its-re><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementPerformance snapshot and why Sabra might be on your radar Sabra Health Care REIT (SBRA) has quietly put together a solid run, with the stock up about 2.5% over the past month and roughly ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/real-estate/nasdaq-sbra/sabra-health-care-reit/news/a-look-at-sabra-health-care-reit-sbra-valuation-after-its-re\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://simplywall.st/stocks/us/real-estate/nasdaq-sbra/sabra-health-care-reit/news/a-look-at-sabra-health-care-reit-sbra-valuation-after-its-re","article_id":"2632795974","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nasdaq-sbra/sabra-health-care-reit/news/a-look-at-sabra-health-care-reit-sbra-valuation-after-its-re","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2632795974","pubTimestamp":1777904546,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Performance snapshot and why Sabra might be on your radar\nSabra Health Care REIT (SBRA) has quietly put together a solid run, with the stock up about 2.5% over the past month and roughly 11% in the past 3 months.\nFor income focused investors watching healthcare real estate, that move, combined with a market value of about US$5.1b and reported annual revenue of US$815.664m, may prompt a closer look at what is driving sentiment.\nSee our latest analysis for Sabra Health Care REIT.\nAt a share...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","XBI":"SPDR S&P Biotech ETF","BK6142":"多户式住宅房地产信托","BK4581":"高盛持仓","BK4203":"医疗保健房地产投资信托","REIT":"ALPS Active REIT ETF","XLV":"健康照护类股ETF-SPDR","LABU":"三倍做多标普生物-Direxion","BK4225":"医疗保健房地产信托","CFA.SI":"NikkoAM-STC Asia REIT","SBRA":"Sabra Healthcare REIT","BK4588":"碎股","8C8U.SI":"Cent Accom REIT"},"translate_title":"萨布拉医疗保健房地产投资信托基金(SBRA)近期股价势头后的估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REIT":1.5,"XLV":1.5,"8C8U.SI":1.5,"XBI":0.6,"SBRA":1.5,"CFA.SI":1.5,"LABU":0.6},"content_text":"AdvertisementPerformance snapshot and why Sabra might be on your radar Sabra Health Care REIT (SBRA) has quietly put together a solid run, with the stock up about 2.5% over the past month and roughly 11% in the past 3 months. For income focused investors watching healthcare real estate, that move, combined with a market value of about US$5.1b and reported annual revenue of US$815.664m, may prompt a closer look at what is driving sentiment. See our latest analysis for Sabra Health Care REIT. At a share price of US$20.36, Sabra’s recent 2.5% 30 day share price return sits alongside a 6.3% year to date gain. Its 1 year total shareholder return of 25.7% and 3 year total shareholder return above 100% point to momentum that has been building over a longer period. If Sabra’s mix of income and real estate exposure has caught your attention, it can be useful to see what else the market is rewarding in related areas such as healthcare focused technology. Consider scanning 33 healthcare AI stocks. With Sabra trading at US$20.36 and sitting at an intrinsic value estimate that implies a sizeable discount, while also showing only a modest gap to analyst targets, the key question is simple: is there still value on the table, or is the market already paying up for future growth? Most Popular Narrative: 7.5% Undervalued Sabra’s fair value in the most widely followed narrative sits at $22.00 versus the last close at $20.36, setting up a modest valuation gap for investors to assess.  The limited new development of senior housing driven by elevated construction and financing costs has created a supply demand imbalance in key markets, giving Sabra pricing power for rent increases and occupancy gains, resulting in expanding margins and boosting net operating income.  Read the complete narrative. Want to see what is behind that pricing power story? The narrative leans heavily on compounding revenue, steady margins and a premium earnings multiple. Curious which assumptions really carry that $22.00 fair value. Result: Fair Value of $22 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, the story can change quickly if new operators underperform, or if reimbursement and regulatory shifts pressure rent coverage and Sabra’s cash flow profile. Find out about the key risks to this Sabra Health Care REIT narrative. Next Steps With both risks and rewards in play, do you feel the balance of this story fits your own view, or does the data point elsewhere? Take a closer look at the 3 key rewards and 2 important warning signs. Looking for more investment ideas? If Sabra has sharpened your focus on income and value, do not stop here. Broaden your watchlist now so you are not late to the next opportunity.  Target resilient returns by checking companies that may offer robust income streams and capital strength through the 13 dividend fortresses. Hunt for potential mispriced opportunities that combine quality with attractive entry points using the 49 high quality undervalued stocks. Secure peace of mind by focusing on companies that show financial strength and resilience through the 72 resilient stocks with low risk scores.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2632795974","isCrawlerRequest":true}